Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

NCT00258700

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Gdansk, Poland
  • GSK Investigational Site Kielce, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

NCT00263653

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Almería, Spain
  • GSK Investigational Site Almería, Spain
  • GSK Investigational Site Antequera/Málaga, Spain
  • GSK Investigational Site Aravaca, Spain
View all 16 locations
View Trial Details
Completed

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

NCT00317122

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +20 more
Locations
  • GSK Investigational Site Brits, South Africa
  • GSK Investigational Site Brits, South Africa
  • GSK Investigational Site Centurion, South Africa
  • GSK Investigational Site Ga-Rankuwa, South Africa
View Trial Details
Completed

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

NCT00290303

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations
  • GSK Investigational Site Manila, Philippines
  • GSK Investigational Site Quezon City, Philippines
  • GSK Investigational Site Sampaloc, Manila, Philippines
View Trial Details

Related conditions